CellSeed Inc. (7776.T)
JPY 535.0
(-1.47%)
JPY 535.0
(-1.47%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 107.15 Million JPY | 75.61% |
| 2022 | 61.01 Million JPY | -27.39% |
| 2021 | 84.03 Million JPY | -39.19% |
| 2020 | 138.18 Million JPY | -36.21% |
| 2019 | 216.62 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 23.79 Million JPY | 32.75% |
| 2024 Q1 | 17.92 Million JPY | -56.17% |
| 2023 Q2 | 22.92 Million JPY | 47.93% |
| 2023 Q4 | 40.89 Million JPY | 46.93% |
| 2023 FY | 107.15 Million JPY | 75.61% |
| 2023 Q1 | 15.49 Million JPY | -15.04% |
| 2023 Q3 | 27.83 Million JPY | 21.43% |
| 2022 Q3 | 6.73 Million JPY | 0.0% |
| 2022 FY | 61.01 Million JPY | -27.39% |
| 2022 Q4 | 18.23 Million JPY | 170.69% |
| 2021 FY | 84.03 Million JPY | -39.19% |
| 2020 FY | 138.18 Million JPY | -36.21% |
| 2019 FY | 216.62 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 94.304% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -33.433% |
| GNI Group Ltd. | 22.43 Billion JPY | 99.522% |
| Linical Co., Ltd. | 3.77 Billion JPY | 97.164% |
| Trans Genic Inc. | 2.24 Billion JPY | 95.236% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -9.061% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 95.683% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 91.71% |
| AnGes, Inc. | -3.06 Billion JPY | 103.496% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 160.295% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 98.891% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 79.285% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | 3.426% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 92.613% |
| CanBas Co., Ltd. | -984 Million JPY | 110.89% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | 72.643% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 93.53% |
| Chiome Bioscience Inc. | 398.59 Million JPY | 73.117% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 89.691% |
| PeptiDream Inc. | 17.21 Billion JPY | 99.378% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -250.123% |
| Ribomic Inc. | -10.5 Million JPY | 1120.329% |
| SanBio Company Limited | -14.5 Million JPY | 838.796% |
| Healios K.K. | 108 Million JPY | 0.782% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 31523.754% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 281.477% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 7186.971% |
| StemRIM | -44.34 Million JPY | 341.618% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 96.636% |
| FunPep Company Limited | -680.28 Million JPY | 115.751% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -54.736% |
| Stella Pharma Corporation | 217.29 Million JPY | 50.688% |
| TMS Co., Ltd. | -6.95 Million JPY | 1641.799% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | 65.935% |
| Cuorips Inc. | 9.63 Million JPY | -1012.605% |
| K Pharma,Inc. | 910 Million JPY | 88.225% |
| Takara Bio Inc. | 25.45 Billion JPY | 99.579% |
| ReproCELL Incorporated | 1.1 Billion JPY | 90.3% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 91.033% |
| StemCell Institute Inc. | 1.57 Billion JPY | 93.2% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 93.571% |